Shandong Tumor Hospital Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Shandong China (1958)

Organization Overview

First Clinical Trial
2013
NCT02004769
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Shandong Tumor Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Squamous Cell (Phase 3)

Esophageal Squamous Cell Carcinoma (Phase 3)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Experimental (Phase 2)

Stomach Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 13